Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial. - Wikidata - wikimedia - TriplyDB

Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial.

Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial.

http://www.wikidata.org/entity/Q34004099

about

Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples Interventions to improve vaginal health for reducing the risk of HIV acquisition Behavioral interventions to reduce the transmission of HIV infection among sex workers and their clients in low- and middle-income countries Interventions for prevention and treatment of vulvovaginal candidiasis in women with HIV infection Randomized controlled trials of interventions to prevent sexually transmitted infections: learning from the past to plan for the future.Periodic presumptive treatment for women with prevalent vaginal infections: secondary analysis of data from a randomized controlled trial.Intravaginal practices, vaginal infections and HIV acquisition: systematic review and meta-analysis.Risky sexual behavior and correlates of STD prevalence among African American HIV serodiscordant couples Prospective study of correlates of vaginal Lactobacillus colonisation among high-risk HIV-1 seronegative women.Determinants of intravaginal practices among HIV-infected women in Zambia using conjoint analysis.Establishing and sustaining a healthy vaginal environment: analysis of data from a randomized trial of periodic presumptive treatment for vaginal infections.Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus.An effective intervention to reduce intravaginal practices among HIV-1 uninfected Kenyan women.Sexually transmitted diseases treatment guidelines, 2015.Changes in sexual risk behavior in the Mombasa cohort: 1993-2007.Loss to follow-up as a competing risk in an observational study of HIV-1 incidence Behavioural and medical predictors of bacterial vaginosis recurrence among female sex workers: longitudinal analysis from a randomized controlled trial.Reaching the unreachable: providing STI control services to female sex workers via mobile team outreach Biological impact of recurrent sexually transmitted infections on HIV seroconversion among women in South Africa: results from frailty models Interventions to prevent sexually transmitted infections, including HIV infection.The posttrial effect of oral periodic presumptive treatment for vaginal infections on the incidence of bacterial vaginosis and Lactobacillus colonization Predictive value of the composition of the vaginal microbiota in bacterial vaginosis, a dynamic study to identify recurrence-related flora.Changes in the contribution of genital tract infections to HIV acquisition among Kenyan high-risk women from 1993 to 2012.Microbiome Composition and Function Drives Wound-Healing Impairment in the Female Genital Tract Impact of Periodic Presumptive Treatment for Bacterial Vaginosis on the Vaginal Microbiome among Women Participating in the Preventing Vaginal Infections Trial.Changes in Vaginal Microbiota and Immune Mediators in HIV-1-Seronegative Kenyan Women Initiating Depot Medroxyprogesterone Acetate.Priority interventions to reduce HIV transmission in sex work settings in sub-Saharan Africa and delivery of these services Prevalence of HIV, sexually transmitted infections, and risk behaviours among female sex workers in Nairobi, Kenya: results of a respondent driven sampling study.Randomized Trial of Periodic Presumptive Treatment With High-Dose Intravaginal Metronidazole and Miconazole to Prevent Vaginal Infections in HIV-negative Women.Efficacy of an HIV intervention in reducing high-risk human papillomavirus, nonviral sexually transmitted infections, and concurrency among African American women: a randomized-controlled trial.Current issues and considerations regarding trichomoniasis and human immunodeficiency virus in African-Americans.Treatment of sexually transmitted infections for HIV prevention: end of the road or new beginning?Vaginal microbiota of women with frequent vulvovaginal candidiasis.Prospective study of vaginal bacterial flora and other risk factors for vulvovaginal candidiasis.Systematic review of sex work interventions in sub-Saharan Africa: examining combination prevention approaches.Assessing and evaluating the combined impact of behavioural and biological risk factors for HIV seroconversion in a cohort of South African women.Vaginal microbiota and susceptibility to HIV.Incidence of unintended pregnancy among female sex workers in low-income and middle-income countries: a systematic review and meta-analysis

P2860

Q21144606-3A3EFC02-A064-483E-B1EA-C6C696018F1A Q24198302-D32D3B47-16F9-4729-B466-BA4BC7EF309A Q24203728-24234089-C1BF-4D93-9EBC-9FAFA7CE9EEA Q24234875-9E7AF52D-F512-4A16-A486-7199110C444F Q24600011-CA0A8983-0A03-4A29-9B2D-ECF7A2042D78 Q30830640-8CF2F906-D7DD-48AC-9755-B895560CD221 Q33531770-C7D57E45-13C1-4754-9347-B2F8E32B6B60 Q33586342-ACE37BCB-3502-43B4-9F33-FBCA90425480 Q33723224-937CC767-5512-46E5-8A8D-4BF60138BF5B Q33771955-29FA522F-AA31-4A0C-82F0-9B009AEAAE83 Q33932523-07C1611A-3AF7-4ED4-9FAB-13D35E44B13C Q34198191-4406A622-B13A-479C-B41F-71C3AE7D86B4 Q34399672-0C0008DE-3D66-4350-A6BE-2D4371AC92AA Q34479272-12450EE7-9642-4344-A4DD-B6871ECDBEB3 Q34557211-5AD217EB-5710-4646-9943-7E02A61666AC Q34649232-CD04AE1D-AEAE-4684-8FB6-D2E548828963 Q34711359-5E411796-784D-42F1-AB0B-9E0BEB809133 Q35055197-9DF9B953-E226-4128-AB50-4701E4604D7A Q35539420-7BE26EDA-54A9-4E6A-AE83-DE0384F3564A Q35542152-02354EE9-BE21-4CE8-8DC1-396D96363408 Q35909803-BC668D06-E123-448A-88F0-3C3333940DDE Q36038001-7D8A7100-668E-42CE-997A-B33E103286B6 Q36076166-EEB209A2-F476-4692-B845-5FFFFAC9EF7E Q36140541-FDEC6D2A-AB2E-47FE-956D-A9AAF00C3037 Q36231982-FF0F392E-DFD4-4587-BF25-8A22FF57CDE3 Q36629905-0CECEB32-92B3-4F1D-98A4-CC2F901C56FF Q36660166-3CC99F6E-7F83-465B-B29B-B6A43C3385FD Q36673085-555C13DB-22AB-47E7-88EF-29AE5B4F41AF Q36812845-3A787546-A2D9-434D-9E1A-7EB556ACB823 Q36856378-3DE588DE-467E-47CF-9D35-383D4489433F Q37050952-942740FB-5658-49EB-8516-067217908C22 Q37307684-DA09657A-E6BE-435C-9C84-40E9E525770B Q37333450-7FF08BBE-36D0-44A9-BA50-8476603A5572 Q37346674-18E23765-7261-485D-B945-C4C33916DDDB Q38884865-3E8777B5-2101-4E0F-81B8-6B4507950178 Q45777444-4A9BADDF-ECAC-4F40-868D-FFA3EDD50929 Q50101300-14847966-A52D-4C3E-A585-44C4DAD4724D Q58732380-9A718E93-47F2-49D8-8EBF-B8FAA688293B

P2860

Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial.

http://www.wikidata.org/entity/Q34004099

description

2008 nî lūn-bûn

@nan

2008 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Improvement of vaginal health ...... results of a randomized trial.

@ast

Improvement of vaginal health ...... results of a randomized trial.

@en

Improvement of vaginal health ...... results of a randomized trial.

@nl

type

label

Improvement of vaginal health ...... results of a randomized trial.

@ast

Improvement of vaginal health ...... results of a randomized trial.

@en

Improvement of vaginal health ...... results of a randomized trial.

@nl

prefLabel

Improvement of vaginal health ...... results of a randomized trial.

@ast

Improvement of vaginal health ...... results of a randomized trial.

@en

Improvement of vaginal health ...... results of a randomized trial.

@nl

P1433

Q34004099-E8CC43A1-396E-4A8D-942F-F03439CA6762

P1476

Q34004099-08B93B42-5A07-4050-A07F-AD5D16AEE37A

P2093

Q34004099-1ED925F7-BBB0-4726-BEF1-6602E270A622

Q34004099-223D3611-014D-4440-9870-D43DE9084B46

Q34004099-3CA2505A-2618-4106-AF56-180E2E2978C9

Q34004099-416176E0-1F14-4FDF-897F-670BE987A110

Q34004099-46EE0544-2C20-4A27-8E2A-103F823FA72E

Q34004099-4A5E04B1-014E-46D9-8FCD-530669B1646F

Q34004099-7E7449A4-CC34-44CA-9EB2-228235AB3A69

Q34004099-A0642C96-D6B9-4DDC-B58E-5DA8F5570EB1

Q34004099-B1CB9FD8-1288-431F-9D58-BA56283B7EF7

Q34004099-BFBD8DB1-2426-4043-8785-74A9517BFC39

P2860

Q34004099-0E110177-73BE-43C6-9C37-57B9647D76CC

Q34004099-29510BD3-AC7F-4799-916C-065E83C672AB

Q34004099-30F74569-FCB0-4C99-9719-9D7A9A9585F8

Q34004099-39D82A63-8C14-4CEE-8177-E90DA6F55662

Q34004099-3AE74EEE-8752-4E2A-8BA7-781676CB966F

Q34004099-47A900BA-AA81-41DD-ABF3-C272CB190AE8

Q34004099-4DE44ADA-A67D-43BF-B337-F7D7E6685D40

Q34004099-50F6F27A-0BE7-47A5-9726-8DD8A79D6719

Q34004099-5B03B5F0-AFE0-4691-834C-658F1EC9415C

Q34004099-5D519C6E-F4C6-40BA-8D28-9EA247B3D9D6

P304

Q34004099-1103363F-45F0-4387-82A8-C766D90ED086

P31

Q34004099-F79EA876-5D46-46DB-A1E8-8BAF9EE5C81E

P356

Q34004099-10F9FE04-D0B6-4A53-8283-70D7682F801D

P407

Q34004099-94729FA5-1ED9-4EC3-B088-C640952FED5E

P433

Q34004099-FD5AAFB1-04D6-437B-920E-50D06D1C3033

P478

Q34004099-5C90528B-2F90-47C2-9DBE-65F7F1E0555D

P577

Q34004099-6531F445-AF4A-4534-BF8A-A1AE51076392

P5875

Q34004099-71627EA6-C280-4E4E-A825-061AB8F3667A

P698

Q34004099-4A3C4C30-E4F4-4174-904D-34AD9D1D7F2A

P921

Q34004099-721BCB3A-7AFA-48F6-886A-742CF3B54954

P932

Q34004099-DD6920B4-2AEF-40D8-8392-1D374C07BCA1

P356

P1433

The Journal of Infectious Diseases

P1476

Improvement of vaginal health ...... results of a randomized trial.

@en

P2093

Ann E Kurth

http://www.w3.org/2001/XMLSchema#string

Barbra A Richardson

http://www.w3.org/2001/XMLSchema#string

James Kiarie

http://www.w3.org/2001/XMLSchema#string

Jared M Baeten

http://www.w3.org/2001/XMLSchema#string

Jeckoniah O Ndinya-Achola

http://www.w3.org/2001/XMLSchema#string

King K Holmes

http://www.w3.org/2001/XMLSchema#string

Kishorchandra Mandaliya

http://www.w3.org/2001/XMLSchema#string

Ludo Lavreys

http://www.w3.org/2001/XMLSchema#string

R Scott McClelland

http://www.w3.org/2001/XMLSchema#string

Vrasha Chohan

http://www.w3.org/2001/XMLSchema#string

P2860

Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation

HIV/AIDS epidemiology, pathogenesis, prevention, and treatment

Intermittent intravaginal antibiotic treatment of bacterial vaginosis in HIV-uninfected and -infected women: a randomized clinical trial.

Sensitivity of Trichomonas vaginalis to metronidazole, tinidazole, and nifuratel in vitro.

Metronidazole in the treatment of non-specific vaginitis (NSV).

Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations.

In-vitro and in-vivo activity of metronidazole against Gardnerella vaginalis, Bacteroides spp. and Mobiluncus spp. in bacterial vaginosis.

A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known?

Pathogenesis and treatment of recurrent vulvovaginal candidiasis.

Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis

P304

1361-1368

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/587490

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

197

http://www.w3.org/2001/XMLSchema#string

P577

2008-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5407231

http://www.w3.org/2001/XMLSchema#string

P698

18444793

http://www.w3.org/2001/XMLSchema#string

P921

P932

4122228

http://www.w3.org/2001/XMLSchema#string